Sorrento Therapeutic...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
Sorrento Therapeutics, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 154 (as per Q2 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker SRNEno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1702468
datesClosing price (adj.)
13.10.20173.30
11.10.20173.70
04.10.20171.78
27.09.20171.75
20.09.20171.70
13.09.20171.80
06.09.20171.80
30.08.20171.80
23.08.20171.65
16.08.20171.68
09.08.20171.75
02.08.20171.90
26.07.20172.05
19.07.20172.00
12.07.20171.95
05.07.20172.00
27.06.20172.05
20.06.20171.75
13.06.20171.60
06.06.20171.55
30.05.20171.60
23.05.20171.58
16.05.20171.70
09.05.20171.70
02.05.20171.93
25.04.20171.90
18.04.20171.60
11.04.20172.95
04.04.20173.50
28.03.20174.00
21.03.20174.15
14.03.20174.05
07.03.20174.75
28.02.20175.20
21.02.20175.25
14.02.20175.70
07.02.20175.50
31.01.20175.40
24.01.20175.30
17.01.20175.35
10.01.20175.90
03.01.20175.05
27.12.20165.30
19.12.20165.10
12.12.20165.15
05.12.20165.30
28.11.20165.60
21.11.20166.15
14.11.20166.55
07.11.20165.15
31.10.20165.75
24.10.20166.89
17.10.20167.05
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 3.30n/a
Market Capitalisation
in million USD
 190n/a
Enterprise Value
in million USD
 125n/a
Common Shares Outstanding
as per Aug 2, 2016
 57,570,468n/a
Preferred Shares Outstanding
as per Aug 2, 2016
 n/a
Average Basic Shares Outstanding
TTM
 39,892,750n/a
Average Diluted Shares Outstanding
TTM
 n/a
Index Membership
n/a
Business Summary
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 4n/a
Gross Profit 3n/a
Operating Income -124n/a
EBITDA 0n/a
Net Profit -88n/a
Balance Sheet
Cash and Cash Equivalents 67n/a
Receivables 0n/a
Total Current Assets 72n/a
PP&E 7n/a
Total Assets 274n/a
Accounts Payable 3n/a
Current Debt 5n/a
Total Current Liabilities 28n/a
Long-Term Debt 3n/a
Total Liabilities 185n/a
Total Equity 89n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 58.9%n/a
Operating Margin -2,862.8%n/a
Net Profit Margin -2,189.8%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS -2.20n/a
Diluted EPS n/a
Sales per Share 0.11n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio -1.50n/a
Price to Sales Ratio 30.40n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.47n/a
Other Ratios
Current Ratio 252.3%n/a
Liabilities to Equity Ratio 207.7%n/a
Debt to Assets Ratio 2.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
1
1
1
0
4
5
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
0
0
0
0
-2
-2
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
1
1
1
0
2
3
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-2
-4
-5
-21
-34
-75
Selling, General & Administrative
-1
-1
-2
-6
-10
-20
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-1
-3
-4
-15
-24
-55
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-2
-3
-5
-21
-32
-73
Non-Operating Income (Loss)
0
0
0
0
-2
-2
Interest Expense, net
0
0
0
0
-2
-2
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-2
-3
-5
-21
-34
-74
Abnormal Gains (Losses)
0
0
0
-1
-2
61
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-2
-3
-5
-22
-36
-14
Income Tax (Expense) Benefit, net
0
0
0
0
2
-36
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-2
-3
-5
-22
-35
-50
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-2
-3
-5
-22
-35
-50
Minority Interest
0
0
0
0
0
4
Net Income
-2
-3
-5
-22
-35
-46
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-2
-3
-5
-22
-35
-46
Remarks
restated on Mar 30, 2012 n/a
calculated values,
restated on Mar 27, 2013 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
5
3
5
32
72
136
Cash & Cash Equivalents
5
3
5
32
72
39
Short Term Investments
0
0
0
0
0
97
Accounts & Notes Receivable
0
0
0
0
1
1
Accounts Receivable, Net
0
0
0
0
0
0
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
0
0
0
0
0
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
0
0
0
1
1
4
Prepaid Expenses
0
0
0
1
1
2
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
2
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
0
0
0
0
0
0
Total Current Assets
6
4
5
33
74
141
Property, Plant & Equipment, Net
0
1
1
2
2
7
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
10
170
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
0
0
0
58
55
25
Intangible Assets
0
0
0
33
4
4
Goodwill
0
0
0
24
24
21
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
27
1
Total Noncurrent Assets
0
1
2
60
68
203
Total Assets
6
5
7
93
142
344
Liabilities and owners' equity
Payables & Accruals
0 403957
0 359339
1 584173
4 4202000
4 4348000
8 7627000
Accounts Payable
0 181799
0 224742
0 439533
2 2153000
2 1656000
1 1339000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 222158
0 134597
0 144640
2 2049000
3 2692000
6 6288000
Short Term Debt
0 0
0 0
0 0
0 374000
3 3316000
5 4835000
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
0 0
0 0
0 0
1 904000
2 1893000
18 18411000
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
1 904000
2 1893000
18 18411000
Total Current Liabilities
0 403957
0 359339
1 584173
5 5480000
10 9557000
31 30873000
Long Term Debt
0 0
0 0
0 0
4 4431000
9 8830000
4 4394000
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
0 200000
0 0
0 0
16 15862000
14 14441000
167 167314000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
1 1497000
1 796000
0 12000
Deferred Revenue
0 200000
0 0
0 0
0 0
1 1024000
111 110900000
Deferred Tax Liabilities
0 0
0 0
0 0
14 14248000
2 1709000
49 49341000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 0
0 0
0 0
0 117000
11 10912000
7 7061000
Total Noncurrent Liabilities
0 200000
0 0
0 0
20 20293000
23 23271000
172 171708000
Total Liabilities
1 603957
0 359339
1 584173
26 25773000
33 32828000
203 202581000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
8 7952324
10 10314480
17 17147730
100 99670000
176 176231000
185 184902000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
-3 -2868500
-6 -6104991
-11 -10950299
-33 -32861000
-68 -67518000
-113 -113329000
Other Equity
0 0
0 0
0 0
0 0
0 0
74 73579000
Equity Before Minority Interest
5 5083824
4 4209489
6 6197431
67 66809000
109 108713000
145 145152000
Minority Interest
0 0
0 0
0 0
0 0
0 0
-4 -4214000
Total Equity
5 5083824
4 4209489
6 6197431
67 66809000
109 108713000
141 140938000
Total Liabilities & Equity
6 5687781
5 4568828
7 6781604
93 92582000
142 141541000
344 343519000
Remarks restated on Mar 30, 2012 n/a restated on Mar 27, 2013 n/a restated on Apr 1, 2014 n/a restated on Mar 16, 2015 n/a restated on Mar 15, 2016 n/a restated on Aug 8, 2016 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-2
-3
-5
-22
-35
-50
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
1
3
2
Non-Cash Items
0
0
1
4
3
-9
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
0
0
0
0
0
15
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
-2
-3
-4
-16
-29
-42
Change in Fixed Assets & Intangibles
0
-1
-1
-1
-1
-4
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
-10
-12
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
0
-1
-1
-1
-11
-15
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
7
8
-3
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
3
2
6
38
72
2
Increase in Capital Stock
3
2
6
38
72
2
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
0
0
0
-1
0
-2
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
3
2
6
44
80
-3
Net Cash Before Disc. Operations and FX
2
-2
2
27
40
-61
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
2
-2
2
27
40
-61
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
2
-2
2
27
40
-61
Remarks
restated on Mar 30, 2012 n/a
calculated values,
restated on Mar 27, 2013 n/a
calculated values,
restated on Mar 16, 2015 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
restated on Mar 15, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo